Atlas Trials

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Clinical trial NCT01206335 · UNKNOWN

Trial details

NCT number
NCT01206335
Sponsor
Ohr Pharmaceutical Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
AnorexiaCancer Cachexia
Start date
2010-09-01
Primary completion
2012-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.